← Open Payments lookup

AMANDA RAY: Open Payments

NPI 1831652080 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$950 in 45 payments from 12 companies in 2025. Trend: 2023 $488 · 2024 $527 · 2025 $950

Food & beverage: $950
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.9$227
Otsuka America Pharmaceutical, Inc.9$169
Alkermes, Inc.8$156
Neurocrine BioSciences, Inc.4$98
Teva Pharmaceuticals USA, Inc.3$67
ABBVIE INC.3$57
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$48
Axsome Therapeutics, Inc.2$40
Bausch Health US, LLC2$33
Tris Pharma Inc1$22

Products named: COBENFY, REXULTI, ARISTADA, INGREZZA, VRAYLAR, CAPLYTA, UZEDY, Auvelity.

Industry payments across TX — which companies pay providers there.